This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Insulet says EOFlow introducing 'magic words' theory at US trial despite court order

( November 11, 2024, 23:10 GMT | Official Statement) -- MLex Summary: South Korean insulin pump patch maker EOFlow is accused of "attempting an end run around" an October ruling by a US judge that rejected EOFlow's theory that trade secrets must be internally labeled as such in order to be entitled to trade secret protection.  In a memorandum, plaintiff Insulet Corporation urged the court to issue a curative instruction to a jury making clear that the Defend Trade Secrets Act has no "magic words" requirement.See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections